Back to Westfield Capital Management Co. LP Westfield Capital Management Co. LP

FATEFATE

Showing 0 of 18 quarters

Position history for Westfield Capital Management Co. LPWestfield Capital Management Co. LP's holdings in Fate Therapeutics, Inc.

No. Westfield Capital Management exited its FATE (Fate Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 1,386,058 shares worth $14M. Westfield Capital Management already held FATE in its Q4 2018 13F, the earliest on record, and held it in 17 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used